Access cutting-edge hepatitis d treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access hepatitis d specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatitis d treatment provided free
This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment.
Sponsor: Vir Biotechnology, Inc.
Check if you qualify for this hepatitis d clinical trial in San Francisco, CA
If you're searching for hepatitis d treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatitis d specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.